Skip to main content

Taclonex Scalp Side Effects

Generic name: betamethasone / calcipotriene topical

Medically reviewed by Last updated on Apr 26, 2024.

Note: This document contains side effect information about betamethasone / calcipotriene topical. Some dosage forms listed on this page may not apply to the brand name Taclonex Scalp.

Applies to betamethasone/calcipotriene topical: topical application cream, topical application foam, topical application ointment, topical application suspension.

Serious side effects of Taclonex Scalp

Along with its needed effects, betamethasone/calcipotriene topical may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking betamethasone / calcipotriene topical:

Less common


Incidence not known

Other side effects of Taclonex Scalp

Some side effects of betamethasone / calcipotriene topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common


Incidence not known

For Healthcare Professionals

Applies to betamethasone / calcipotriene topical: topical cream, topical foam, topical ointment, topical suspension.


Very common (10% or more): Pruritus (17%)

Common (1% to 10%): Skin exfoliation

Uncommon (0.1% to 1%): Skin infection, folliculitis, skin atrophy, exacerbation of psoriasis, dermatitis, erythema, rash (e.g., exfoliative, papular, pustular), purpura, ecchymosis, skin burning sensation, skin irritation

Rare (less than 0.1%): Furuncle, pustular psoriasis, skin striae, photosensitivity reaction, acne, dry skin[Ref]

Nervous system

Very common (10% or more): Headache (16%)[Ref]


Rare (less than 0.1%): Hypercalcemia, hyperglycemia[Ref]


Very common (10% or more): Adrenal suppression (15%)

Rare (less than 0.1%): Cushing's syndrome[Ref]


Rare (less than 0.1%): Hypersensitivity[Ref]


Very common (10% or more): Nasopharyngitis (11%)

Common (1% to 10%): Upper respiratory tract infection[Ref]


Uncommon (0.1% to 1%): Application site pigmentation changes, application site pain/burning[Ref]


Frequency not reported: Vision blurred[Ref]

Frequently asked questions

More about Taclonex Scalp (betamethasone / calcipotriene topical)

Patient resources

Other brands

Enstilar, Wynzora

Professional resources

Other brands

Enstilar, Wynzora

Other formulations

Related treatment guides


1. (2022) "Product Information. Taclonex (betamethasone-calcipotriene topical)." Leo Pharma Inc

2. (2022) "Product Information. Enstilar (betamethasone-calcipotriene topical)." Leo Pharma Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.